14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AKAO
Delisted

Achaogen Stock Price (Quote)

NASDAQ Stock Exchange
Open Broker Account
$0.102
+0 (+0%)
At Close: Dec 02, 2020
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.102 $0.102 Wednesday, 2nd Dec 2020 AKAO stock ended at $0.102. During the day the stock fluctuated 0% from a day low at $0.102 to a day high of $0.102.
90 days $0.102 $0.102
52 weeks $0.102 $0.102

Historical Achaogen prices

Date Open High Low Close Volume
Apr 26, 2019 $0.0700 $0.0970 $0.0560 $0.0820 7 391 762
Apr 25, 2019 $0.110 $0.190 $0.100 $0.110 48 269 301
Apr 24, 2019 $0.118 $0.130 $0.103 $0.108 9 755 504
Apr 23, 2019 $0.159 $0.160 $0.130 $0.137 4 291 562
Apr 22, 2019 $0.175 $0.175 $0.151 $0.152 4 783 845
Apr 18, 2019 $0.178 $0.179 $0.163 $0.175 2 846 546
Apr 17, 2019 $0.178 $0.195 $0.172 $0.184 7 472 796
Apr 16, 2019 $0.160 $0.220 $0.159 $0.163 26 689 396
Apr 15, 2019 $0.222 $0.330 $0.145 $0.156 34 888 178
Apr 12, 2019 $0.460 $0.520 $0.460 $0.495 1 101 571
Apr 11, 2019 $0.507 $0.530 $0.480 $0.486 492 043
Apr 10, 2019 $0.506 $0.540 $0.489 $0.507 1 617 889
Apr 09, 2019 $0.480 $0.535 $0.480 $0.516 1 323 675
Apr 08, 2019 $0.545 $0.545 $0.501 $0.520 1 443 647
Apr 05, 2019 $0.550 $0.569 $0.518 $0.538 1 863 190
Apr 04, 2019 $0.519 $0.600 $0.490 $0.520 4 172 924
Apr 03, 2019 $0.430 $0.500 $0.420 $0.480 2 178 371
Apr 02, 2019 $0.437 $0.444 $0.415 $0.434 1 839 928
Apr 01, 2019 $0.468 $0.470 $0.420 $0.437 1 174 171
Mar 29, 2019 $0.410 $0.485 $0.400 $0.456 2 294 134
Mar 28, 2019 $0.480 $0.488 $0.451 $0.460 2 395 181
Mar 27, 2019 $0.510 $0.524 $0.470 $0.471 1 764 180
Mar 26, 2019 $0.528 $0.536 $0.483 $0.500 2 295 366
Mar 25, 2019 $0.525 $0.540 $0.503 $0.515 1 114 088
Mar 22, 2019 $0.549 $0.558 $0.520 $0.520 1 632 731
Click to get the best stock tips daily for free!

About Achaogen

Achaogen, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antibacterials to treat multi-drug resistant (MDR) gram-negative infections in the United States. The company is principally developing plazomicin, which is in Phase III clinical trial for the treatment of serious bacterial infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. It is also involved in the resear... AKAO Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT